nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

01.04.2015 | Retinal Disorders

Early spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes

verfasst von: Xiaofei Chen, Huanfen Zhou, Yan Gong, Shihui Wei, Maonian Zhang

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Microglial activation has been recognized as a neuropathological feature in diabetic retinopathy. But the early spatiotemporal characterization of microglial activation in the retina and the optic nerve of diabetic animals has not been fully investigated. The purpose of this study was to investigate early sequential changes of microglia in the retinas of rats with streptozotocin-induced diabetes. Microglia in the optic nerves of rats with streptozotocin-induced diabetes were also studied.

Methods

In 4-week, 8-week, and 12-week diabetic and normal control rats, microglial activation in the retinas and optic nerves was evaluated by immunolabeling with OX-42 antibody. Density, proportion of activation, and laminar distribution of retinal microglia were quantified. The retinal mRNA level of Iba-1, a microglial-specific marker, was measured by real-time PCR.

Results

The density of retinal microglia was not different between diabetic and control rats, but the proportion of activated microglia increased significantly in diabetic rats at each time point. The proportion of microglia increased obviously in the nerve fiber layer and the ganglion cell layer while decreasing in the inner plexiform layer in 12-week diabetic rats. Moreover, retinal Iba-1 mRNA expression increased in 8-week and 12-week diabetic rats. Processes of microglia in the optic nerves of control rats were aligned with the long axis of nerve fibers, while the alignment was disturbed in diabetic rats.

Conclusions

Morphology, proportion of activation, distribution, and mRNA expression of retinal microglia changed characteristically with the progression of the disease in early-stage diabetic rats.

Moss S, Klein R, Klein B (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105:998–1003CrossRefPubMed

Bunce C, Xing W, Wormald R (2010) Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye (Lond) 24:1692–1699CrossRef

Gardner T, Antonetti D, Barber A, LaNoue K, Levison S (2002) Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 47(Suppl 2):S253–S262CrossRefPubMed

Fletcher E, Phipps J, Wilkinson-Berka J (2005) Dysfunction of retinal neurons and glia during diabetes. Clin Exp Optom 88:132–145CrossRefPubMed

Kern T (2007) Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007:95103CrossRefPubMedCentralPubMed

Kim Y, Joh T (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson’s disease. Exp Mol Med 38:333–347CrossRefPubMed

Zeng H, Green WR, Tso MOM (2008) Microglial activation in human diabetic retinopathy. Arch Ophthalmol 126:227–232CrossRefPubMed

Rungger–Brändle E, Dosso AA, Leuenberger PM (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1971–1980PubMed

Gaucher D, Chiappore J-A, Pâques M, Simonutti M, Boitard C, Sahel J, Massin P, Picaud S (2007) Microglial changes occur without neural cell death in diabetic retinopathy. Vis Res 47:612–623CrossRefPubMed

10.

Zeng X, Y-k NG, E-a L (2000) Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 11:463–471CrossRef

11.

Moss A, Beggs S, Vega-Avelaira D, Costigan M, Hathway G, Salter M, Fitzgerald M (2007) Spinal microglia and neuropathic pain in young rats. Pain 128:215–224CrossRefPubMed

12.

Sandhir R, Onyszchuk G, Berman N (2008) Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Exp Neurol 213:372–380CrossRefPubMedCentralPubMed

13.

Robinson A, White T, Mason D (1986) Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRS OX-42, the latter recognising complement receptor type 3. Immunology 57:239–247PubMedCentralPubMed

14.

Davis E, Foster T, Thomas W (1994) Cellular forms and functions of brain microglia. Brain Res Bull 34:73–78CrossRefPubMed

15.

Raibon E, Sauvé Y, Carter D, Gaillard F (2002) Microglial changes accompanying the promotion of retinal ganglion cell axonal regeneration into peripheral nerve grafts. J Neurocytol 31:57–71CrossRefPubMed

16.

Hanisch U, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387–1394CrossRefPubMed

17.

Streit W (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133–139CrossRefPubMed

18.

Krady J, Basu A, Allen C, Xu Y, LaNoue K, Gardner T, Levison S (2005) Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54:1559–1565CrossRefPubMed

19.

Arnal E, Miranda M, Johnsen-Soriano S, Alvarez-Nölting R, Díaz-Llopis M, Araiz J, Cervera E, Bosch-Morell F, Romero FJ (2009) Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Curr Eye Res 34:928–938CrossRefPubMed

20.

Qiao H, Hisatomi T, Sonoda K, Kura S, Sassa Y, Kinoshita S, Nakamura T, Sakamoto T, Ishibashi T (2005) The characterisation of hyalocytes: the origin, phenotype, and turnover. Br J Ophthalmol 89:513–517CrossRefPubMedCentralPubMed

21.

Marie O, Thillaye-Goldenberg B, Naud M, de Kozak Y (1999) Inhibition of endotoxin-induced Uveitis and potentiation of local TNF-a and interleukin-6 mRNA expression by interleukin-13. Invest Ophthalmol Vis Sci 40:2275–2282PubMed

22.

Ohsawa K, Kohsaka S (2011) Dynamic motility of microglia: purinergic modulation of microglial movement in the normal and pathological brain. Glia 59:1793–1799CrossRefPubMed

23.

Ibrahim A, El-Remessy A, Matragoon S, Zhang W, Patel Y, Khan S, Al-Gayyar M, El-Shishtawy M, Liou G (2011) Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 60:1122–1133CrossRefPubMedCentralPubMed

24.

Hanisch U (2002) Microglia as a source and target of cytokines. Glia 40:140–155CrossRefPubMed

25.

Zeng H, Zhu X, Zhang C, Yang L, Wu L, Tso M (2005) Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest Ophthalmol Vis Sci 46:2992–2999CrossRefPubMed

26.

Kowluru R, Odenbach S (2004) Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Invest Ophthalmol Vis Sci 45:4161–4166CrossRefPubMed

27.

Demircan N, Safran B, Soylu M, Ozcan A, Sizmaz S (2006) Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (Lond) 20:1366–1369CrossRef

28.

Kitaoka Y, Kitaoka Y, Kwong J, Ross-Cisneros F, Wang J, Tsai R, Sadun A, Lam T (2006) TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Invest Ophthalmol Vis Sci 47:1448–1457CrossRefPubMed

29.

Berger S, Savitz S, Nijhawan S, Singh M, David J, Rosenbaum P, Rosenbaum D (2008) Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 49:3605–3610CrossRefPubMed

30.

Morgan S, Taylor D, Pocock J (2004) Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades. J Neurochem 90:89–101CrossRefPubMed

31.

YZ L, CH L, FC C, CM H (2005) Molecular mechanisms responsible for microglia-derived protection of Sprague–Dawley rat brain cells during in vitro ischemia. Neurosci Lett 373:159–164CrossRef

32.

Yune T, Lee J, Jung G, Kim S, Jiang M, Kim Y, Oh Y, Markelonis G, Oh T (2007) Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci 27:7751–7761CrossRefPubMed

33.

Wang A, Yu A, Lau L, Lee C, Wu M, Zhu X, Tso M (2005) Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int 47:152–158CrossRefPubMed

34.

Chen M, Ona V, Li M, Ferrante R, Fink K, Zhu S, Bian J, Guo L, Farrell L, Hersch S, Hobbs W, Vonsattel J, Cha J, Friedlander R (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797–801CrossRefPubMed

35.

Wang J, Wei Q, Wang C, Hill W, Hess D, Dong Z (2004) Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279:19948–19954CrossRefPubMed

Titel: Early spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes
verfasst von: Xiaofei Chen
Huanfen Zhou
Yan Gong
Shihui Wei
Maonian Zhang
Publikationsdatum: 01.04.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 4/2015
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-014-2727-y

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Early spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes

Abstract

Background

Methods

Results

Conclusions

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Acquired adenoma of the nonpigmented ciliary epithelium: analysis of five cases

Dehydroxymethylepoxyquinomicin, a novel nuclear factor–κB inhibitor, reduces chemokines and adhesion molecule expression induced by IL-1β in human corneal fibroblasts

Retinal vessel diameter measurements by spectral domain optical coherence tomography

Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization

Retinal vascular caliber between eyes with asymmetric glaucoma

Accommodative changes produced in response to overnight orthokeratology

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde